We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Weight-loss drug developers line ... Eli Lilly's treatment for early Alzheimer's, providing patients with another option after Eisai and Biogen's Leqembi received approval in January, the company ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Eli Lilly's biggest catalyst at the moment comes from its hit weight loss medications, Mounjaro and Zepbound. Lilly is ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best safe stocks to buy according to analysts. Statistically, November and December tend ...

and further bolster the company's revenue and profit base by augmenting its fast-growing weight loss operation. The bottom line I see Lilly as the superior investment over Novo Nordisk -- and ...

Eli Lilly and Company LLY announced that its board of directors approved a new $15 billion share buyback plan. The earlier $5 billion stock repurchase plan ended in the fourth quarter of 2024.

On October 28, Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend of $1.30 per share, which was in line with its previous dividend. Overall, the company has been growing its ...

China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option ...